Cargando…
P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431112/ http://dx.doi.org/10.1097/01.HS9.0000970388.90596.a3 |
_version_ | 1785091122711756800 |
---|---|
author | Alsina, Melissa Dhodapkar, Madhav Berdeja, Jesus Patel, Krina Richard, Shambavi Vij, Ravi Leleu, Xavier Egan, Daniel Leif Bergsagel, P. Ran, Reshef Usmani, Saad Z Truppel-Hartmann, Anna Basudhar, Debashree Thompson, Ethan Zheng, Xirong Zhong, Xiaobo Greggio, Chiara Popa Mckiver, Mihaela Carrasco Alfonso, Marlene Siegel, David |
author_facet | Alsina, Melissa Dhodapkar, Madhav Berdeja, Jesus Patel, Krina Richard, Shambavi Vij, Ravi Leleu, Xavier Egan, Daniel Leif Bergsagel, P. Ran, Reshef Usmani, Saad Z Truppel-Hartmann, Anna Basudhar, Debashree Thompson, Ethan Zheng, Xirong Zhong, Xiaobo Greggio, Chiara Popa Mckiver, Mihaela Carrasco Alfonso, Marlene Siegel, David |
author_sort | Alsina, Melissa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431112 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104311122023-08-17 P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C Alsina, Melissa Dhodapkar, Madhav Berdeja, Jesus Patel, Krina Richard, Shambavi Vij, Ravi Leleu, Xavier Egan, Daniel Leif Bergsagel, P. Ran, Reshef Usmani, Saad Z Truppel-Hartmann, Anna Basudhar, Debashree Thompson, Ethan Zheng, Xirong Zhong, Xiaobo Greggio, Chiara Popa Mckiver, Mihaela Carrasco Alfonso, Marlene Siegel, David Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431112/ http://dx.doi.org/10.1097/01.HS9.0000970388.90596.a3 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Alsina, Melissa Dhodapkar, Madhav Berdeja, Jesus Patel, Krina Richard, Shambavi Vij, Ravi Leleu, Xavier Egan, Daniel Leif Bergsagel, P. Ran, Reshef Usmani, Saad Z Truppel-Hartmann, Anna Basudhar, Debashree Thompson, Ethan Zheng, Xirong Zhong, Xiaobo Greggio, Chiara Popa Mckiver, Mihaela Carrasco Alfonso, Marlene Siegel, David P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C |
title | P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C |
title_full | P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C |
title_fullStr | P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C |
title_full_unstemmed | P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C |
title_short | P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C |
title_sort | p871: idecabtagene vicleucel (ide-cel) in patients with an inadequate response to frontline autologous stem cell transplantation (asct): results from karmma-2 cohort 2c |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431112/ http://dx.doi.org/10.1097/01.HS9.0000970388.90596.a3 |
work_keys_str_mv | AT alsinamelissa p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT dhodapkarmadhav p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT berdejajesus p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT patelkrina p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT richardshambavi p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT vijravi p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT leleuxavier p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT egandaniel p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT leifbergsagelp p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT ranreshef p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT usmanisaadz p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT truppelhartmannanna p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT basudhardebashree p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT thompsonethan p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT zhengxirong p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT zhongxiaobo p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT greggiochiara p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT popamckivermihaela p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT carrascoalfonsomarlene p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c AT siegeldavid p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c |